At the moment Oncosec seems more interested in spreading their technology around to other companies to move it forward while not fronting any money. If something big comes from a TAP collaboration then I would expect some decent money heading to Oncosec, I would hope. At this point the TAP deals will yield no money as stated in the Jounce PR- "For SEC reporting purposes, the agreement between OncoSec and Jounce is non-material". If some really good news comes out of these TAP deals I think much bigger fish may start throwing around tasty offers to buyout the company that could be too good to pass up.
News 
Market Data 
Discover 
